Article Text
Statistics from Altmetric.com
In the world of dementia, and particularly of Alzheimer's disease, few phrases are more likely to polarise opinion than ‘mild cognitive impairment’ (MCI). After something of a cottage industry of publications covering the definition, epidemiology and treatment of MCI, many researchers now feel that this is a redundant concept, as what is required is a term that accurately and reliably represents the earliest stages of Alzheimer's disease. As such, there has been a greater emphasis on the use of specific neuropsychological assessments, neuroimaging and other biomarkers with the hope that these will reduce the numbers of MCI patients who fail to evolve into any form of dementia.1
However, the year 2012 saw the publication of new criteria for the definition of MCI in Parkinson's disease (PD), based on a literature review and expert consensus.2 Are such criteria likely to be useful in aiding our understanding of the progression of cognitive decline in PD and identifying people at high risk of developing dementia associated with Parkinson's disease (PDD)? Or do they merely add an unwanted element of complexity, and divert research energy from early detection of the underpinning pathophysiological …
Footnotes
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed. This paper was reviewed by Simon Lewis, Sydney, Australia.
Read the full text or download the PDF:
Other content recommended for you
- Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy
- Cognitive impairment in Parkinson's disease
- Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study
- Grey matter atrophy in cognitively impaired Parkinson's disease
- Functional brain imaging of cognitive dysfunction in Parkinson's disease
- CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- Poor attentional function predicts cognitive decline in patients with non-demented Parkinson’s disease independent of motor phenotype
- White matter integrity and cognition in Parkinson's disease: a cross-sectional study
- Brain iron deposition is linked with cognitive severity in Parkinson’s disease
- Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson’s disease